Dr. Maureen A. Kane, Associate Professor at the School of Pharmacy and Executive Director of the Mass Spectrometry Center, University of Maryland (A Waters Center of Innovation), discusses the state-of-the-art facilities the center provides to academics working in drug discovery and development worldwide. Learn how the latest mass spectrometry technology facilitates the identification of injury-related biomarkers that can be used in the development of therapeutics.